Algernon Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 2, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020	2015 - 2019
Market Capitalization	2	3	3	13	17	45	Upgrade
Market Cap Growth	84.25%	10.13%	-79.52%	-24.12%	-62.61%	627.75%	Upgrade
Enterprise Value	2	2	2	12	13	36	Upgrade
Last Close Price	0.09	0.10	0.17	1.13	2.09	6.91	Upgrade
PB Ratio	1.30	1.32	1.77	2.26	1.84	3.67	Upgrade
P/TBV Ratio	-	-	-	34.49	4.25	6.23	Upgrade
Quick Ratio	0.20	0.35	0.08	0.82	4.60	12.11	Upgrade
Current Ratio	0.23	0.42	0.13	1.12	4.80	12.75	Upgrade
Return on Equity (ROE)	-25.89%	-27.62%	-191.06%	-82.15%	-72.51%	-99.34%	Upgrade
Return on Assets (ROA)	-35.42%	-35.41%	-50.99%	-39.28%	-42.89%	-58.17%	Upgrade
Return on Capital (ROIC)	-96.19%	-79.11%	-88.61%	-48.70%	-46.16%	-61.46%	Upgrade
Earnings Yield	-15.62%	-17.55%	-260.51%	-47.64%	-46.18%	-19.06%	Upgrade
FCF Yield	-133.09%	-94.52%	-98.08%	-22.92%	-46.71%	-14.76%	Upgrade
Buyback Yield / Dilution	-37.20%	-32.35%	-117.87%	-11.59%	-76.84%	-97.19%	Upgrade

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.